PHARMACODYNAMICS OF CYCLOSPORINE-KETOCONAZOLE INTERACTION IN MICE - COMBINED THERAPY POTENTIATES CYCLOSPORINE IMMUNOSUPPRESSION AND TOXICITY

被引：23

作者：

ANDERSON, JE

MORRIS, RE

BLASCHKE, TF

机构：

[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV CLIN PHARMACOL,STANFORD,CA 94305

[2] STANFORD UNIV,MED CTR,SCH MED,DEPT CARDIOVASC SURG,TRANSPLANTAT IMMUNOL LAB,STANFORD,CA 94305

来源：

关键词：

D O I：

10.1097/00007890-198704000-00015

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：529 / 533

页数：5

共 34 条

[1] ANDERSON JE, 1986, J PHARMACOL EXP THER, V236, P671
[2] CYCLOSPORINE NEPHROTOXICITY
BENNETT, WM
PULLIAM, JP
[J]. ANNALS OF INTERNAL MEDICINE, 1983, 99 (06) : 851 - 854
[3] EFFECT OF KETOCONAZOLE ON HEPATIC OXIDATIVE DRUG-METABOLISM
BROWN, MW
MALDONADO, AL
MEREDITH, CG
SPEEG, KV
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) : 290 - 297
[4] CUNNINGHAM C, 1983, TRANSPLANT P, V15, P2712
[5] AMELIORATION OF CYCLOSPORIN-INDUCED NEPHROTOXICITY IN RATS BY INDUCTION OF HEPATIC DRUG-METABOLISM
CUNNINGHAM, C
BURKE, MD
WHEATLEY, DN
THOMSON, AW
SIMPSON, JG
WHITING, PH
[J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (04) : 573 - 578
[6] DANIELS NJ, 1984, LANCET, V2, P639
[7] DIEPERINK H, 1982, LANCET, V2, P1217
[8] FERGUSON RM, 1982, LANCET, V2, P882
[9] FIDELUS RK, 1983, TRANSPLANT P, V15, P1921
[10] EVALUATION OF CYCLOSPORIN PHENYTOIN INTERACTION WITH OBSERVATIONS ON CYCLOSPORIN METABOLITES
FREEMAN, DJ
LAUPACIS, A
KEOWN, PA
STILLER, CR
CARRUTHERS, SG
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) : 887 - 893